Naproxen
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
ApoNapro ACTIVE contains naproxen, which is an anti-inflammatory, analgesic, and antipyretic medicine. It belongs to a group of medicines called NSAIDs (nonsteroidal anti-inflammatory drugs). ApoNapro ACTIVE is used in adults and adolescents from 16 years of age for short-term treatment of pain and fever. ApoNapro ACTIVE can relieve pain and inflammation (swelling, redness, and heat) and is used to treat adults in cases of:
Do not take this medicine if any of the above situations apply to you. If in doubt, talk to a doctor or pharmacist before taking this medicine. If at any time during treatment you experience any of the following symptoms, STOP TAKING the medicine and seek medical help immediately:
STOP TAKING the medicine and tell your doctor if you experience:
If you have heart problems, have had a stroke, or think you may be at risk of these conditions (for example, due to high blood pressure, diabetes, high cholesterol, or smoking), you should discuss your treatment with a doctor or pharmacist. Before taking this medicine, you should talk to a doctor or pharmacist if you have any of the following:
Severe skin reactions, including exfoliative dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms (DRESS) have been reported with the use of ApoNapro ACTIVE. STOP TAKING ApoNapro ACTIVE and seek medical help immediately if you experience any symptoms related to these severe skin reactions described in section 4. Elderly people may have an increased risk of side effects. You should tell your doctor immediately if you experience any unusual symptoms related to the stomach or intestines. If any of the above situations apply to you or if you are unsure, talk to a doctor or pharmacist before taking this medicine.
This medicine should not be taken by children and adolescents under 16 years of age.
Tell your doctor or pharmacist about all the medicines you are taking now or have taken recently, including those available without a prescription and herbal medicines. In particular, tell your doctor or pharmacist if you are taking:
If any of the above situations apply to you or if you are unsure, talk to a doctor or pharmacist before taking this medicine.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Do not take ApoNapro ACTIVE if you are in the last three months of pregnancy, as it may harm the unborn baby or cause complications during delivery. ApoNapro ACTIVE may cause kidney and heart problems in the unborn baby. It may also increase the risk of bleeding in the mother and baby and prolong labor. During the first six months of pregnancy, do not take ApoNapro ACTIVE unless your doctor considers it absolutely necessary. If treatment is necessary during this period or when trying to conceive, use the lowest possible dose for the shortest possible time. From the 20th week of pregnancy, ApoNapro ACTIVE may cause kidney problems in the unborn baby if taken for more than a few days, which may lead to low levels of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of the blood vessel (ductus arteriosus) in the baby's heart. If treatment is required for a longer period, your doctor may recommend additional monitoring.
Naproxen passes into breast milk. ApoNapro ACTIVE is not recommended for use in breastfeeding women.
Naproxen may make it more difficult to become pregnant. You should tell your doctor if you are planning to become pregnant or are having trouble becoming pregnant.
This medicine may cause drowsiness, dizziness, or blurred vision, as well as depression or disorientation. It may also cause disturbances in vision and balance. If you experience any of these symptoms, talk to a doctor, and do not drive or operate any tools or machines.
This medicine contains 345 mg (15 mmol) of sodium (the main component of common salt) per effervescent tablet. This corresponds to 17.2% of the maximum recommended daily intake of sodium in the diet for adults.
Sorbitol is a source of fructose. If you have previously been diagnosed with intolerance to some sugars or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which the body does not break down fructose, you should talk to a doctor before taking this medicine.
Taking medicines containing naproxen may be associated with a small increased risk of heart attack or stroke. The risk is higher with higher doses and longer treatment. DO NOT EXCEED THE RECOMMENDED DOSE OR DURATION OF TREATMENT. This medicine should always be taken as directed by a doctor or pharmacist. If in doubt, talk to a doctor or pharmacist. Dissolve 1 to 2 tablets in a glass (150 mL) of water and drink, 3 tablets should be dissolved in 300 mL. To ensure that no medicine remains, rinse the empty glass with a small amount (10 mL) of water and drink. Take with food or after food. If you have a sensitive stomach, take ApoNapro ACTIVE with food. You should make sure you drink enough fluids and are well-hydrated while taking this medicine. This is especially important if you have kidney problems. While taking this medicine, your doctor will want to see you to check that you are taking the right dose and that no side effects occur. This is especially important for elderly patients.
Muscle, joint, or tendon pain, painful menstruation, and fever
ApoNapro ACTIVE should not be taken by children and adolescents under 16 years of age, as the active substance content is too high. In adolescents aged 16 and over, the recommended daily dose is 20 mg/kg body weight per day. Do not exceed the daily dose of 1000 mg per day.
Your doctor will decide on the dose, which will usually be lower than for other adults.
Overdose symptoms may include stomach pain, nausea, and vomiting. Headaches, dizziness, drowsiness, vision disturbances, and ringing in the ears may occur, as well as loss of consciousness. High blood pressure, respiratory depression, and coma may occur after taking NSAIDs, but are rare. If you suspect an overdose of ApoNapro ACTIVE, seek medical help immediately. Take the medicine packaging with you. If you feel that the medicine is not providing sufficient pain relief, do not increase the dose yourself; talk to a doctor immediately.
If you miss a dose, skip it and take the next dose at the usual time. Do not take a double dose to make up for a missed dose.
Like all medicines, ApoNapro ACTIVE can cause side effects, although not everybody gets them. Taking medicines containing naproxen may be associated with a small increased risk of heart attack or stroke.
Frequency not known: frequency cannot be estimated from the available data
Severe stomach and intestinal problems,symptoms include:
Allergic reactions,symptoms include:
Severe skin reactions,symptoms include:
Liver problems,symptoms include:
Heart attack,symptoms include:
Stroke,symptoms include:
Meningitis,symptoms include:
If you notice any of the serious side effects listed above, STOP TAKING the medicine and tell your doctor immediately.
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. By reporting side effects, you can help provide more information on the safety of this medicine. Side effects can also be reported to the marketing authorization holder.
Keep this medicine out of the sight and reach of children. Do not take this medicine after the expiry date stated on the carton after EXP. The expiry date refers to the last day of the month stated. There are no special storage precautions for this medicine. Store in the original packaging to protect from moisture. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is naproxen. Each effervescent tablet contains 250 mg of naproxen. The other ingredients are: citric acid, sodium bicarbonate, sodium carbonate, sodium cyclamate (E 952), sodium saccharin (E 954), sodium citrate, povidone (K 30), macrogol (6000), mannitol (E 421), simethicone, sodium docusate, Cassis flavor (containing maltodextrin, mannitol (E 421), gluconolactone (E 575), sorbitol (E 420), arabic gum (E 414), colloidal silica anhydrous (E 551)).
Round, white effervescent tablets (diameter 25 mm). ApoNapro ACTIVE is available in packs of 10 and 20. Not all pack sizes may be marketed.
Aurovitas Pharma Polska Sp. z o.o. ul. Sokratesa 13D lokal 27 01-909 Warsaw e-mail: medicalinformation@aurovitas.pl
HERMES PHARMA GmbH Hans-Urmiller-Ring 52 82515 Wolfratshausen Germany
Poland: ApoNapro ACTIVE Date of last revision of the leaflet:04/2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.